We will be in Brussels to support CXS Therapeutics during its meetings with a foundation that works on rare diseases. Let's meet on the occasion of this trip.

One to One meeting with investors/LP - get in touch, we still have a few slots left

The capital increase was completed in the middle of August. Welcome Thomas and Guilain, PR to follow.

The lifting of the SAPPIENS program exceeds half of its objective. Learn more in private.